Teladoc Adds Susan Salka to Expanded Board of Directors
End of Quarter Sale - 50% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Teladoc ( (TDOC) ) has provided an announcement.
On March 30, 2026, Teladoc Health, Inc. increased the size of its board of directors to nine members and appointed experienced healthcare executive Susan R. Salka as a director, effective immediately. Salka, the former president and CEO of AMN Healthcare Services, joins the audit and compensation committees, with the board determining she is an independent director and an audit committee financial expert under New York Stock Exchange and SEC rules.
Her appointment follows the retirements of Eric Evans and Thomas McKinley and the addition of Michael Smith, signaling continued board refreshment at the virtual care company. Teladoc expects to draw on Salka’s long track record in healthcare workforce solutions and M&A‑driven growth as it pursues care delivery transformation and its next phase of scale and value creation, with her compensation and indemnification aligned to existing non‑employee director arrangements.
During her 33‑year tenure at AMN Healthcare, Salka helped drive strategic and operational expansion, including 26 acquisitions and growth to more than $5 billion in revenue. Her broader board experience at companies such as Parexel International, McKesson Corporation and Beckman Coulter adds governance depth that may strengthen Teladoc’s oversight and strategic capabilities in a competitive virtual care market.
The most recent analyst rating on (TDOC) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Teladoc stock, see the TDOC Stock Forecast page.
Spark’s Take on TDOC Stock
According to Spark, TipRanks’ AI Analyst, TDOC is a Neutral.
The score is anchored by improving financial durability—strong free cash flow and reduced leverage—partly offset by ongoing GAAP losses and modest/flat revenue trends. Technicals are notably weak (below key moving averages with negative MACD), and the earnings call points to stability rather than reacceleration, with BetterHelp and policy/financing risks limiting upside.
To see Spark’s full report on TDOC stock, click here.
More about Teladoc
Teladoc Health, Inc. is a global leader in virtual care, delivering and orchestrating healthcare services across patients, providers, platforms and partners. Through relationships with health plans, employers, providers, health systems and consumers, the company focuses on expanding access, improving outcomes, extending provider capacity and lowering healthcare costs.
The company positions virtual care as a catalyst for more efficient and effective health delivery worldwide, leveraging technology-enabled services to integrate care at scale. Its market focus spans enterprise clients and individual consumers, aiming to drive outcomes‑focused, integrated care models across the healthcare ecosystem.
Average Trading Volume: 6,407,290
Technical Sentiment Signal: Sell
Current Market Cap: $917M
For detailed information about TDOC stock, go to TipRanks’ Stock Analysis page.
